Gallagher Fiduciary Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$503K Buy
2,272
+19
+0.8% +$4.65K 0.02% 160
2025
Q4
$571K Buy
2,253
+72
+3% +$18.1K 0.02% 160
2025
Q3
$540K Buy
2,181
+28
+1% +$6.7K 0.02% 150
2025
Q2
$517K Buy
2,153
+102
+5% +$23.7K 0.02% 171
2025
Q1
$465K Buy
2,051
+81
+4% +$17.8K 0.02% 165
2024
Q4
$405K Buy
1,970
+63
+3% +$13.8K 0.08% 170
2024
Q3
$463K Buy
1,907
+215
+13% +$50.3K 0.09% 125
2024
Q2
$371K Buy
1,692
+309
+22% +$67.1K 0.08% 128
2024
Q1
$311K Buy
1,383
+196
+17% +$44.2K 0.01% 146
2023
Q4
$261K Buy
1,187
+3
+0.3% +$634 0.01% 157
2023
Q3
$260K Buy
1,184
+7
+0.6% +$1.58K 0.02% 146
2023
Q2
$265K Buy
1,177
+2
+0.2% +$400 0.02% 175
2023
Q1
$225K Buy
+1,175
New +$227K 0.02% 184

Other funds holding STE

Gallagher Fiduciary Advisors's STE Position: Q1 2026 in Review

Gallagher Fiduciary Advisors increased its Steris (STE) stake by 0.84% in Q1 2026, buying an estimated $4.65K and bringing the position to 2,272 shares worth $503K. The position accounts for 0.02% of the portfolio, ranked #160.

Gallagher Fiduciary Advisors first reported a position in STE in Q1 2023 and has held it in 13 quarters since. The position peaked at $571K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Gallagher Fiduciary Advisors held 2,272 shares of Steris worth $503K as of Q1 2026.
  • Gallagher Fiduciary Advisors bought 19 Steris shares in Q1 2026, an estimated $4.65K.
  • Steris made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q1 2026, its #160 holding.
  • Gallagher Fiduciary Advisors first reported a position in Steris in Q1 2023 and has held it in 13 quarters since.
  • Gallagher Fiduciary Advisors's Steris position peaked at $571K in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q1 2026, filed 15 May 2026.